
1. angew chem int ed engl. 2016 jan 11;55(2):664-8. doi: 10.1002/anie.201509345.
epub 2015 nov 24.

production new cladosporin analogues reconstitution polyketide
synthases responsible biosynthesis antimalarial agent.

cochrane rv(1), sanichar r(1), lambkin gr(1), reiz b(1), xu w(2), tang y(2),
vederas jc(3).

author information: 
(1)department chemistry, university alberta, edmonton, alberta, t6g 2g2
(canada).
(2)department chemical biomolecular engineering department of
chemistry biochemistry, university california, los angeles, ca 90095
(usa).
(3)department chemistry, university alberta, edmonton, alberta, t6g 2g2
(canada). john.vederas@ualberta.ca.

the antimalarial agent cladosporin nanomolar inhibitor plasmodium
falciparum lysyl-trna synthetase, exhibits activity blood- and
liver-stage infection. cladosporin isolated fungus cladosporium
cladosporioides, biosynthesized highly reducing (hr) a
non-reducing (nr) iterative type i polyketide synthase (pks) pair. genome
sequencing host organism subsequent heterologous expression these
enzymes saccharomyces cerevisiae produced cladosporin, confirming identity
of putative gene cluster. incorporation pentaketide intermediate
analogue indicated 5+3 assembly hr pks cla2 nr pks cla3 during
cladosporin biosynthesis. advanced-intermediate analogues synthesized and
incorporated cla3 furnish new cladosporin analogues. putative lysyl-trna 
synthetase resistance gene identified cladosporin gene cluster.
analysis active site emphasizes key structural features thought be
important resistance cladosporin.

© 2016 wiley-vch verlag gmbh & co. kgaa, weinheim.

doi: 10.1002/anie.201509345 
pmcid: pmc4906947
pmid: 26783060  [indexed medline]

